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Abstract. Activation of blood platelets triggers a series 
of responses leading to the formation and retraction of 
blood clots. Among these responses is the establish- 
ment of integrin-mediated transmembrane  connections 
between extracellular matrix components and the actin 
cytoskeleton of the platelet.  Here we report that a  spe- 
cific subpopulation of the major platelet integrin,  gly- 
coprotein IIb-IHa (GPIlb-HIa) (also referred to as 
ottr~3 integrin),  becomes incorporated into the deter- 
gent-insoluble actin cytoskeleton of platelets during 
the platelet activation response. The cytoskeletal asso- 
ciation of GPIIb-lIla is independent of platelet aggre- 
gation and fibrin sedimentation and is sensitive to 
cytochalasin D  treatment.  As determined by Western 
immunoblot analysis, ~,,22 % of the total cellular 
GPIIb-IIIa becomes associated with the actin 
cytoskeleton upon thrombin activation in a manner 
that is independent of the detection of talin,  ot-actinin, 
or vinculin in the complex. We found that the 
cytoskeleton-associated GPllb-llla is derived from an 
intracellular  source since it is not available for 
lactoperoxidase-catalyzed radioiodination before plate- 
let activation.  Two intracellular  sources of GPIIb-IIIa 
are present in resting platelets:  GPl/b-IIIa associated 
with the a-granule secretory compartment as well as 
surface-inaccessible domains of the surface-connected 
canalicular system. Interestingly,  a-granule  secretion, 
which occurs in thrombin-activated platelets and 
results in the translocation of intracellular  GPHb-INa 
to the plasma membrane,  appears to be required for 
the cytoskeleton incorporation of GPllb-IIIa that we 
observe. Collectively, our data provide evidence that a 
subpopulation of GPIIb-INa derived from an intracel- 
lular source is selectively linked to the actin cyto- 
skeleton of platelets upon thrombin activation in the 
absence of platelet aggregation. 
p 
LATELETS are anucleate cells that  participate  in the 
processes of hemostasis and thrombosis.  Platelets ex- 
hibit highly regulated adhesion.  They circulate in the 
bloodstream in a resting,  nonadhesive  state.  Upon exposure 
to stimuli at the site of injury to a blood vessel, platelets be- 
come activated,  undergo a dramatic  shape change,  and de- 
velop the capacity to adhere to each other and to the blood 
vessel wall  (for review  see Zucker and Nachmias,  1985). 
Subsequent platelet aggregation,  which occurs when acti- 
vated platelets interact with each other, as well as the platelet- 
dependent retraction of the fibrin clot, prevent further bleed- 
ing from the site of injury. 
When platelets become activated and adhesive they estab- 
lish a transmembrane connection between their contractile 
machinery and the extracellular  matrix, a process that is es- 
sential  for  platelet-mediated  clot  retraction.  This  highly 
regulated  process is thought  to proceed via an activation- 
dependent reorganization  of proteins to generate a  trans- 
membrane link between extracellular  fibrin  and the actin 
cytoskeleton of the platelet.  One group of proteins capable 
of mediating interactions  between cytoplasmic proteins and 
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the extracellular  environment is the integrin family. Integrins 
are transmembrane,  heterodimeric (orB) glycoproteins that 
serve as receptors for extracellular  matrix components (for 
review see Hynes, 1987; Ruoslahti and Pierschbacher,  1987; 
Albelda and Buck, 1990). It has recently been shown that the 
cytoplasmic domain of the receptor is also essential for cer- 
tain aspects of integrin  function.  In vitro binding  studies as 
well as analysis of cells transfected  with/~-integrin  deletion 
constructs have revealed that the cytoplasmic domain of inte- 
grin is required both for receptor localization  at focal con- 
tacts (Solowska et al., 1989; Marcantonio et al., 1990) and 
for association with the cytoskeleton (Horwitz et al., 1986; 
Tapley et al., 1989; Otey et al., 1990). The duality of integrin 
function makes proteins in this family likely candidates  for 
mediating transmembrane interactions between extracellular 
matrix components and the cytoplasmic actin cytoskeleton. 
The  major  extracellular  matrix  receptor  on  the  plate- 
let surface,  the glycoprotein complex GPllb-I]Ia  =  tXnd$3 
(GPI~-I]Ia) 1,  is  a  member of the integrin  family of cell 
adhesion  molecules consisting  of the ctnb and/33  subunits. 
1. Abbreviations used in this paper:  GPllb-IIIa, glycoprotein IIb-IIIa  = 
tXXlb~3 integrin; PVDF, polyvinylidine difluoride; SCCS, surface-connected 
canalicular system. 
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tor (Bennett and Vilaire, 1979; Marguerie et al., 1979; Ben- 
nett et al.,  1983;  Parise and Phillips,  1985)  as well as a 
receptor for fibronectin (Ginsberg et al.,  1983;  Parise and 
Phillips, 1986), yon Willebrand factor (Rugged et al., 1982), 
and vitronectin (Pytela et al., 1986). GPI/b-IIIa may also in- 
teract with other extracellular matrix components, such as 
collagen (Kotite et al.,  1984;  Shade et al.,  1984).  Ligand 
binding by GPIIb-IIIa is dependent on platelet activation (for 
review see Phillips et al., 1988; Plow and Ginsberg, 1989). 
Recent studies suggest that activation of platelets by throm- 
bin and other agonists leads to a conformational change in 
the GPIIb-IIIa complex which enables GPIIb-IIIa to function 
as an active receptor (Shattil et al., 1985b;  Frelinger et al., 
1988;  O'Toole et al.,  1990;  Duet al.,  1991). The highly 
regulated process  of platelet aggregation is  known to be 
mediated by GPIIb-IlIa binding to fibrinogen (Bennett and 
Vilaire,  1979;  Marguerie et al.,  1979;  Peerschke  et al., 
1980).  Additionally, GPllb-IIIa has been shown to be as- 
sociated with the actin cytoskeleton in aggregated platelets 
(Phillips et al., 1980; Painter and Ginsberg, 1982).  GPIIb- 
IIIa is therefore believed to link the actin cytoskeleton of 
platelets to extracellular matrix components. 
In addition to mediating a structural connection between 
extracellular and cytoplasmic compartments, integrins may 
participate directly in transmembrane signal transduction. In 
a variety of cells, the binding of integrins to their extracellu- 
lar ligands leads to the activation of signaling molecules 
including tyrosine kinases, ion channels, and transcription 
factors that could regulate adhesion-stimulated changes in 
cell behavior. In platelets for example, the tyrosine kinase 
pp125 F^K is activated by integrin engagement (Lipfert et al., 
1992).  Interestingly, the activation of pp125 F^K is blocked if 
the actin cytoskeleton is perturbed by pretreatment of the 
platelets with cytochalasin D (Lipfert et al., 1992), an obser- 
vation that points out the importance of the actin cytoskele- 
ton in the signal transduction response. Taken together with 
the demonstration that tyrosine kinase activity can be stimu- 
lated by integrin clustering (Kornberg et al., 1991), an event 
that is widely postulated to require a cytoskeletal linkage in 
vivo, it appears that integrin signaling potential may depend 
on both receptor engagement and cytoskeleton attachment. 
The molecular mechanism by which actin is linked to inte- 
grins in platelets has not been defined. In other cell types, 
such as fibroblasts, a number of proteins have been identified 
that are thought to mediate actin-membrane interactions (for 
review see Burridge et al.,  1988;  Crawford and Beckerle, 
1990; Beckerle and Yeh, 1990; Geiger and Ginsberg, 1991; 
Luna et al., 1992). Talin has been shown to interact with the 
cytoplasmic domain of the/31 subunit of integrin (Horwitz 
et al., 1986; Buck and Horwitz, 1987) as well as with vincu- 
lin (Otto,  1983;  Burridge and Mangeat,  1984).  Vinculin, 
in turn, can associate with the actin cross-linking protein, 
ot-actinin (Belkin and Koteliansky, 1987; Wachsstock et al., 
1987). This series of  protein-protein interactions could form 
a bridge between the cytoplasmic actin cytoskeleton and the 
transmembrane receptors  for extracellular matrix compo- 
nents, thereby linking the contractile machinery of the cell 
to the substratum. Other mechanisms have also been pro- 
posed by which actin-membrane interactions could be medi- 
ated in cells. For example, ~actinin, which has been shown 
to bind to/31  and/33 integrin subunits in vitro (Otey et al., 
1990),  could  serve  to  link integrin directly to  the  actin 
cytoskeleton or actin itself may be directly linked to the 
membrane (Painter et al.,  1985b). 
We have used  a  biochemical approach  to  examine the 
regulated development and molecular composition of inte- 
grin-cytoskeleton linkages in platelets. Here we report that 
22 % of the cellular GPIIb-IIIa becomes associated with the 
actin  cytoskeleton  of  thrombin-activated,  nonaggregated 
platelets.  This  is  a  novel finding since previously it was 
reported that the linkage of GPIlb-llIa to the actin cytoskele- 
ton was a late response to agonist that depended on platelet 
aggregation (Phillips  et al.,  1980;  Painter and Ginsberg, 
1982). Furthermore, we show here that the incorporation of 
GPIIb-IIIa into the actin cytoskeleton is a selective process 
involving a  specific  subpopulation  of GPIIb-IIIa derived 
from an intracellular pool. 
Materials and Methods 
Platelet Isolation and Activation 
Washed human platelets were prepared  from freshly drawn whole blood 
from aspirin-free, adult donors essentially as described by Fox and Phillips 
(1982) except that we centrifuged the platelet-rich plasma at 560 g  for 20 
min, washed the platelets two times in a 37°C citrate-glucose-sodium chlo- 
ride solution (13 mM sodium citrate dihydrate, 30 mM glucose,  120 mM 
sodium chloride, pH 7), and isolated the platelets after each wash by cen- 
trifugation at 560 g  for  15 min.  Platelets were resuspended in Tyrode's 
buffer  (138  mM  NaC1,  2.9  mM  KC1,  12  mM  NaHCO3,  0.36  mM 
Na2HPO4,  5.5 mM  glucose,  1.8 mM CaC12,  and 0.49 mM MgCI2) at a 
concentration of 109 platelets/ml (as counted using a hemacytometer) and 
allowed to incubate at 37°C  for 30-60  min to restore a  resting, discoid 
shape (Nachmias, 1980; Fox et al.,  1984). Platelets were activated with ei- 
ther thrombin (0.1 U/ml, Calbiocbem-Novabiochem Corp., La Jolla, CA) 
or ADP (100/zM, Sigma Chem. Co., St. Louis, MO) for 15 min in the ab- 
sence of stirring to prevent platelet aggregation. One minute before deter- 
gent lysis, 5 mM EDTA/5 mM EGTA was added to resting and activated 
platelet samples to increase the stability of the actin cytoskeletons during 
their isolation. We obtain essentially identical results if divalent cations are 
chelated 15 rain before platelet activation. To examine the importance ofac- 
tin filament assembly, resting platelets were treated with cytochalasin D 
(Sigma Chem. Co.) in ethanol (2.5  x  10  -5 M cytochalasin D in 0.5% eth- 
anol) or ethanol alone for 1 h immediately after their isolation. 
Platelet activation and aggregation were monitored using a Model 500 
Lumi-Aggregometer  (Chrono-Log Corp.,  Havertown,  PA).  Additionally, 
small aliquots of resting and activated platelets were taken from the ex- 
perimental samples and fixed in preparation for light microscopic observa- 
tion. Fixed samples were viewed by phase contrast microscopy to confirm 
that  the  resting  platelets  exhibited  a  discoid  shape  and  that  thrombin- 
activated samples had undergone a shape change but were not aggregated. 
If these conditions were not met, the samples were discarded. 
Isolation and Analysis of Platelet Lysates 
Platelets were lysed 15 rain after activation. Detergent-soluble and insoluble 
platelet fractions were prepared  using a  modification of the method de- 
scribed by Phillips et al. (1980). Intact resting and activated platelets in solu- 
tion were lysed by mixing with one volume ofa 2x Triton lysis buffer con- 
talning 2% Triton X-100,  0.01 M EGTA, 0.01 M  EDTA, 0.1 M  Tris-HCl, 
pH 7.4, and the protease inhibitors leupeptin (2 ×  10  -5 M), phenylmethyl- 
suifonyl fluoride (0.2 raM), benzamidine HC1 (0.2 mM), pepstatin A  (2 
ng/ml), and 1,10-phenanthroline (2 ng/ml) (Sigma Chem. Co.) in Tyrode's 
buffer. To inhibit thrombin activity, hirudin (final concentration, 0.2 U/ml) 
was added immediately before lysis. After detergent treatment, the samples 
were spun in an Eppendorf microcentdfuge (Brinkmann Instrs. Co., West- 
bury, NY) for 4 rain at 8,730 g (Phillips ~et al., 1980). The detergent-soluble 
fraction (supernatant) was mixed at a ratio of 2:1 with 3 x  Laemmli sample 
buffer (Laemmli,  1970)  and boiled for 4  rain.  The detergent-insoluble 
pellets were washed without resuspension in lx detergent lysis buffer and 
recentrifuged.  The final pellets were resuspended in 200/~L of Ix  lysis 
buffer plus 100/zL of 3 x  Laemmli sample buffer and boiled for 4 min. As 
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centrated five times relative to the detergent-soluble samples. The proteins 
present in each fraction were resolved by 10% SDS-PAGE as described by 
Laemmli (1970)  except that the bisacrylamide concentration was 0.13%. 
Molecular mass markers were purchased from Bio-Rad Labs. (Hercules, 
CA). Folypeptide bands were detected by staining the gels with Coomassie 
brilliant blue (Sigma Chem. Co.) Western immnnoblot analysis was per- 
formed according to the method of Towbin et al. (1979) with the modifica- 
tions described by Beckerle (1986). The 125I-protein A used in immunoblots 
was purchased from ICN Biomedicals, Inc. (Irvina, CA). Densitometry was 
performed on Coomassie blue-stained gels and autoradiograms using either 
a Sony CCD (monochrome-charged couple device) video camera attached 
to a Macintosh IIci computer with an NIH Image 1.36 software package or 
the Phosphor Imager (model 400E) with an Image Quant 3.2 software pack- 
age (Molecular Dynamics). Because of the large amounts of actin present 
in cytoskeletai pellets isolated from both resting and thrombin-activated 
platelets, differences in actin content between these samples could only be 
detected by video densitometry of Coomassie blue-stained gels on which 
smaller amounts of protein were loaded. 
Iodination of  Platelets 
Aliquots of platelets (109 cells/ml) were radiolabeled at room temperature 
by adding 1 mCi Na-125I (Amersham Corp., Arlington Heights, IL) per ml 
platelets, 4.2 U/ml lactoperoxidase (Sigma Chem. Co.) in PBS (2.7 mM 
KCI, 1.1 mM KH2PO4,  138 mM NaCI, 8.1 mM Na2HPO4.7H20, 0.1 mM 
CaCI2,  and 1 mM MgCI2),  20 mM/3-D-glucose (Sigma Chem. Co.), and 
0.025 U/ml glucose oxidase (Sigma Chem. Co.) which catalyzes the genera- 
tion of H202 from the/3-o-glucose substrate (Schenkein et al., 1972).  The 
samples were incubated for 10 rain with frequent stirring. Saturated tyrosine 
solution was then added and samples were incubated an additional 5 rain. 
The reaction volume was then raised to 10 ml with a washing buffer contain- 
ing 0.154 M NaCI, 0.01 M Tris-HC1,  0.001 M EDTA, pH 7.4 (Phillips and 
Agin, 1977).  The radiolabeled platelets were sedimented by centrifugation, 
washed once more, and resuspended to the original volume in Tyrode's 
buffer.  Control samples were subjected to the same treatment, with the ex- 
ception that unlabeled NaI was used in place of Na-t25I, and were analyzed 
by Western immnnoblot. Activation of iodinated platelets and isolation of 
actin cytoskeletons were performed as described above. Similar results in 
terms of cytoskeletal composition and the amount of iodinated GPHb-IIIa 
associated with the cytoskeletons were obtained for platelets activated in the 
presence of divalent cations and those activated in the presence of divalent 
cation chelators. Radiolabeled proteins were resolved by 7.5 % SDS-PAGE 
and visualized by autoradiography. 
Antibody Preparation and Characterization 
B11 and B5 rabbit polyclonal antisera were raised against human platelet 
talin and GPIIb-IIIa, respectively (Beckerle et al.,  1989).  When used for 
Western blots of two-dimensional gels (O'Farrell,  1975)  of total human 
platelet protein, the B5 antibody recognized a single pair of spots corre- 
sponding to authentic GPIlb-IIIa (data not shown). Additionally, no detect- 
able bands were present when B5 antibody was used for Western immuno- 
blots of total platelet protein from Glanzmann thrombasthenlc platelets (our 
unpublished observations) which lack detectable GPIIb-IlIa (Glanzmann 
thrombastbenic platelets were provided by Dr. Paul Bray, Johns Hopkins 
University, Baltimore, MD). B15 antiserum was raised against human plate- 
let vinculin. Anti-a-actinin antibody was the generous gift of Dr. Keith Bur- 
ridge (University of North Carolina, Chapel Hill, NC) and was raised in 
rabbits against bovine cardiac c~-actinln. These antibodies were character- 
ized by Western immunoblot analysis as described in the text. $12 monoclo- 
hal antibody against the c~-granule membrane glycoprotein, P-selectin, and 
a goat anti-human P-selectin pelyclonal antibody were the generous gifts 
of Dr. Rodger E  McEver (University of Oklahoma, Oklahoma City, OK) 
and have been extensively characterized (McEver and Martin, 1984;  Sten- 
berg et al., 1985).  The rabbit polyclonal antibody against human fibrinogen 
was obtained from Cappel Labs., (Durham, N.C.). 
Fluorescence Microscopy 
Rhodamine PhaUoidin Labeling of Intact Cells and Actin Cytoskeletons. 
Platelet  lysates  were  prepared  from  samples  of resting  and  thrombin- 
activated platelets as described above. Samples of detergent-lysed platelets 
(400/~L) were fixed in 3 vol of 3.7 % formaldehyde in PBS. These samples 
were  then  diluted  with  Tyrode's  buffer (total  volume,  5  ml),  and  the 
detergent-insoluble material  was centrifuged (130  g) onto Alcian blue- 
coated coverslips placed on inserts in the bottom of 15 mL Corex tubes. The 
coverslips were then rinsed in TBS (150 mM NaC1, 50 mM Tris-HCl, pH 
7.6, 0.1% sodium azide) for 5 rain at room temperature, incubated in 1% 
BSA in TBS for 30 rain at 37°C, rinsed for 10 rain in TBS, and incubated 
in rhodamine-labeled phalloidin (Molecular Probes Inc., Eugene, OR) at 
a dilution of 1:50 in TBS for 1 h at 37°C. The coverslips were then rinsed 
in TBS for 10 min and mounted on slides using Gelvatol (Air Prods. & 
Chem. Inc., Allentown, PA). 
Indirect  Immunofluorescence.  Fixed samples of resting and activated 
platelets were prepared for indirect immunofluorescence  as described previ- 
ously (Beckerle et al., 1989).  The $12 antibody against P-selectin was used 
at a concentration of 2/zg/mi to stain unpermeabilized cells. The secondary 
antibody, rhodamine-labeled goat anti-mouse IgG,  was purchased from 
Cappel Labs. Photomicrographs were taken on a fluorescence microscope 
(Axiophot; Carl Zeiss Inc., Thornwood, NY) equipped with a 100x Plan- 
Neofluor objective. Quantitative analysis of P-selectin expression on plate- 
let  surfaces  was performed as  follows:  the platelets were observed by 
differential interference contrast microscopy and fields containing 25 or 
more platelets were selected at random and photographed. The same fields 
were then photographed for fluorescent staining. The percentage of cells ex- 
hibiting a detectable ring of fluorescence, representative of significant S12 
binding, was then determined for 300-600 cells under each condition in in- 
dependent experiments using a different blood donor for each experiment. 
Inhibition of a-Granule Secretion 
The  c~-granule  release  response  of  thrombin-stimulated  platelets  was 
prevented by adding the metabolic inhibitors 2-deoxyglucose (15 mM in 
0.15 M NaC1) and gluconolactone (20 mM in 0.15 M NaCl) to samples of 
resting platelets 5  min before thromhin addition (Holmsen et al.,  1974; 
Tuszynski et al., 1982).  To verify that these metabolic inhibitors did indeed 
block a-granule secretion, we performed indirect immunofluorescence on 
fixed, unpermeabilized samples of inhibitor-treated platelets using the $12 
antibody against P-selectin. Although t~-granule  secretion was blocked, 
activation-dependent shape change still occurred, as observed by phase con- 
trast microscopy. Twofold higher concentrations of the inhibitors blocked 
shape change as well as secretion, while twofold lower concentrations did 
not have a significant effect on the secretion response. Because of concerns 
regarding the toxicity of these metabolic inhibitors on platelets, individual 
experiments in which normal, resting platelet morphology was altered or 
thrombin-stimulated shape change failed to occur, were excluded from fur- 
ther analysis. The addition of 0.15 M  NaCl alone had no effect on either 
the platelet activation response or the activation-dependent incorporation of 
GPIIb-IIIa into the actin cytoskeleton. 
Protein Microsequencing 
Polyacrylamide gels (10 %) were made with recrystallized SDS (Hunkapiller 
et al.,  1983) and pre-run for 2 h at 25 V in running buffer containing 50 
/~M glutathione (Sigma Chem. Co.) (Yuen et al., 1986; Moos et al., 1988). 
The running buffer was changed before sample electmphoresis, and  100 
mM sodium thioglycolate (Sigma Chem. Co.) was added to a final concen- 
tration ofO.1 mM (Hunkapiller et al., 1983; Yuen et al., 1986; Moos et al., 
1988).  These free radical scavengers were added to prevent destruction of 
amino acid side chains by oxidants and free radicals in the gel (Hunkapiller 
et al., 1983).  After sample electrophoresis, the proteins were electroeluted 
onto polyvinylidine difluoride (PVDF) membranes (Millipore Corp., Bed- 
ford, MA) (Matsudaira,  1987; Yuen et al.,  1988).  The PVDF membranes 
were then stained with Coomassie blue (Matsudaira, 1987) and the ll0-kD 
band was excised and stored at  -20°C.  The protein was sequenced on a 
model 477A protein sequencer (Applied Biosystems Inc., Foster City, CA). 
The amino acid sequence was analyzed using the University of Wisconsin 
GCG  software package (University of Wisconsin Biotechnology Center, 
Madison, WI). 
Results 
Platelets can be isolated in the resting state and then activated 
in vitro by exposure to a variety of agonists. The activation 
process can be monitored by light microscopy as well as ag- 
gregometry. Resting platelets exhibit a characteristic discoid 
shape by light microscopy and do not aggregate spontaneously 
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Figure 1.  Aggregometer tracings of resting, activated, and aggre- 
gated platelets. Suspensions of resting platelets (R) are turbid, al- 
lowing little light to transmit through the sample. In response to 
thrombin activation  (arrowheads), platelets undergo  a shape change 
as marked by a decrease in light transmission (arrow). When acti- 
vated platelets contact each other (A:Plus stir) they form aggregates 
allowing an increasing amount of  light to transmit through the sam- 
ple. The addition of  divalent  cation chelators (A:Plus  EGTA/EDTA) 
or the absence of stirring (A:Minus stir) prohibits platelet aggrega- 
tion; however, shape change still occurs. 
as  shown  by  aggregometer tracings  (Fig.  1,  R).  Activa- 
tion-dependent shape change (arrow) occurs almost immedi- 
ately after the addition of 0.1  NIH U/ml thrombin (arrow- 
heads).  When suspensions of thrombin-activated platelets 
are stirred in the presence of divalent cations, such as Mg  2÷ 
and Ca  2+, the platelets aggregate as demonstrated by an in- 
crease in light transmitted through the sample (Fig. 1 A: Plus 
stir). It is possible to prevent platelet aggregation by incubat- 
ing the activated cells without stirring to minimize plate- 
let-platelet contact (Fig. 1 A: Minus stir) or by adding diva- 
lent  cation  chelators  before  activation  (Fig.  1  A:  Plus 
EGTA/EDTA). Incubation of platelets at 37°C in the pres- 
ence of divalent cation chelators results in dissociation of 
plasma membrane-associated GPIIb-UIa complexes which 
prevents fibrinogen binding and completely inhibits platelet 
aggregation (Zucker and Grant, 1978; Jennings and Phillips, 
1982;  Carrell et al.,  1985;  Fitzgerald and Phillips,  1985; 
Shattil et al.,  1985a;  Pidard et al.,  1986). 
Platelets exhibit elaborate actin cytoskeletons which are 
thought to be important in the contractile response of these 
cells (Fox,  1985;  Fox et al.,  1988).  Results of a variety of 
morphological and biochemical studies have demonstrated 
that the cytoplasmic actin filament network undergoes a dra- 
matic reorganization upon platelet activation, enabling plate- 
lets  to  participate  in blood clot formation and retraction 
(Nachmias,  1980;  Jennings et al.,  1981; Fox and Phillips, 
1983;  Fox et al.,  1984).  It is possible to isolate a complex 
containing filamentous actin and associated proteins from 
resting or activated, nonaggregated platelets by detergent ly- 
sis of the cells in the presence of divalent cation chelators 
and protease inhibitors followed by centrifugation at low g 
forces. We refer to this detergent-insoluble complex as the 
actin cytoskeleton or platelet cytoskeleton throughout the 
text. As can be seen in Fig. 2 B, actin cytoskeletons isolated 
from activated platelets by this method are brightly labeled 
with rhodamine phalloidin which reveals the presence of 
Figure 2. Actin-rich cytoskeletal structures are present in the iso- 
lated detergent-insoluble  material. The distribution of filamentous 
actin in intact, thrombin-activated  platelets is compared to that in 
the isolated detergent-insoluble  cytoskeletons by rhodamine phal- 
loidin labeling. A shows  the organization  of filamentous  actin in ac- 
tivated platelets. Actin-rich filopodia extend from the surfaces of 
activated platelets (arrows). The cytoskeletal structures in B are 
similar in size to intact cells and are rich in filamentous actin. Bar, 
5 gm. 
filamentous  actin.  These  structures  exhibit  a  stellate, 
platelet-sized morphology (see Fig. 2 A for comparison to 
intact platelets). As will be shown in later figures, actin and 
myosin are the two most prominent proteins present in these 
preparations which supports our contention that the isolated 
material does indeed represent a cytoskeletal fraction. Our 
ability to isolate significant amounts of cytoskeletal material 
was dependent on the presence of divalent cation chelators 
at least 1 min before detergent lysis (not shown). We believe 
that the chelators stabilize the cytoskeletons during cell lysis 
and centrifugation, as has been suggested by others (Rosen- 
berg et al.,  1982;  Fox et al.,  1988). 
We have used SDS-PAGE and Western immunoblot analy- 
sis to study the molecular composition of the isolated cyto- 
skeletons. In particular we have examined whether GPRb- 
IIIa, talin, ~actinin, and vinculin become incorporated into 
the actin cytoskeleton of platelets in an activation-depen- 
dent, aggregation-independent manner. All of these proteins 
have  been  postulated  to  play  pivotal  roles  in  forming 
membrane-actin cytoskeleton linkages (Luna et al.,  1992). 
The specificity of the polyclonal antibodies against GPIIb- 
ma,  talin,  ot-actinin,  and vinculin is demonstrated in the 
Western immunoblots shown in Fig.  3.  We examined the 
polypeptide composition of the actin cytoskeletons isolated 
from resting and thrombin-activated platelets (Fig. 4 A). Ac- 
tin (A, 43 kD) and myosin (M, 200 kD) are the primary con- 
stituents of the isolated cytoskeletons. Some actin-binding 
protein (ABP, 250 It)), or filamin, is also associated with the 
cytoskeletal pellets. As has been noted by previous investiga- 
tors (Phillips et al., 1980; Pribluda and Rotman, 1982; Fox 
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IRa, talin, a-actinin, and vinculin. The specificity of  the antibodies 
used in our studies is shown here by Western immunoblot analysis. 
(A) A Coomassie blue-stained gel of  molecular mass standards (M) 
and total human platelet protein (P). (B) Parallel Western immuno- 
blots of human platelet proteins probed with the following anti- 
bodies:  anti-GPl/b-iRa  (llb-llla),  anti-talin  (T),  anti-c~-actinin 
(or-A), and anti-vinculin (V). 
and Phillips, 1983; Tuszynski et al., 1985), we detect the as- 
sociation of several new proteins cosedimenting with the ac- 
tin cytoskeleton upon platelet activation (compare lanes Rp 
and Ap in Fig. 4 A). For example, we detect a polypeptide 
at '~110 kD in actin cytoskeletons isolated from platelets ac- 
tivated in  the presence of Ca  ~+ and  Mg  2+  (Fig.  4  A,  lane 
Ap).  Although this protein migrates close to the position of 
ot-actinin on 10% polyacrylamide gels, by Western immuno- 
blot analysis we have determined that this ll0-kD polypep- 
tide is not o~-actinin (not shown). To identify this protein, the 
electrophoretically isolated protein was subjected to direct 
microsequence analysis.  We  obtained  15  amino  acids  of 
NH2-terminal  sequence  and  determined  that  the  sole  se- 
quenceable protein migrating with an apparent mass of 110 
kD is "y-fibrinogen (Fig. 5). The 50-kD 3,-tibrinogen subunit 
self-associates to generate covalently linked dimers when 
platelets are activated with thrombin in the presence of Ca  2+ 
(McDonagh and McDonagh,  1972; Fox et al.,  1983). It is 
formally possible that other proteins are also present at this 
molecular weight but are NH2-terminally blocked and there- 
fore failed to be sequenced. 
Western  immunoblot analysis was used to examine the 
cytoskeletons of resting and thrombin-activated platelets for 
the presence of the major platelet integrin, GPl/b-IIIa. As 
can be seen in Fig. 4 B, the amount of GPllb-llla incorpo- 
Figure 4. An activation-dependent increase in the amount of  GPRb- 
IRa associated with the platelet cytoskeleton. Resting or thrombin- 
activated platelets  that  had  been  incubated  in  the  presence  of 
Ca++/Mg++ were treated with EGTA/EDTA for 1 min, lysed with 
Triton  X-100-containing buffer, and centrifuged to separate the 
detergent-soluble  (supernatant)  and  detergent-insoluble  (pellet) 
fractions.  (A) A Coomassie blue-stained  gel of molecular mass 
standards (M), total human platelet protein (T), resting platelet su- 
pernatant (Rs), resting platelet pellet (Rp), activated platelet super- 
natant (As), and activated platelet pellet (Ap). As loaded on the gels, 
pellet samples are five times more concentrated than supernatant 
samples.  Arrows point  to actin-binding protein  (ABP),  myosin 
(M), a 110-kD protein (110), and actin (A). (B) A corresponding 
Western immunoblot probed with an antibody against GPllb-iRa. 
The amount of GPlIb-IIIa associated with the detergent-insoluble, 
cytoskeletal fraction increases in an activation-dependent manner. 
rated  into  the  detergent-insoluble  actin  cytoskeleton  in- 
creases upon platelet activation. We observed that ,,022 % of 
the total GPllb-RIa pool is associated with actin cytoskele- 
tons isolated from thrombin-activated, nonaggregated plate- 
lets (Table D. In the experiment shown here (Fig. 4), resting 
and activated platelets were maintained at 37°C without stir- 
ring in a physiological buffer containing the divalent cations 
Ca  2+ and Mg  ~+, and divalent cation chelators were added to 
the platelet suspensions 1 min before lysis, a step required 
for the effective isolation of the cytoskeletons. Immediately 
before lysis, small aliquots were removed from each platelet 
sample  and  fixed for light microscopic evaluation of cell 
morphology; we determined directly that no platelet aggre- 
gation had occurred in the thrombin-activated samples we 
analyzed. Parallel samples were evaluated for the extent of 
platelet aggregation using a lumiaggregometer and, consis- 
tent with our light microscopic analysis, no aggregation was 
detected. Similar results in terms of both cytoskeletal com- 
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110  kDa  NH2  -  Y%rATRDNXX  I  LDERF  - 
IIIIIII  IIIIII 
7-Fbg  NH2-YVATRDNCC  ILDERF- 
Figure5. Comparison of  the first fifteen amino acids of  7-fibrinogen 
and a 100-kD protein associated with cytoskeletons isolated from 
thrombin-activated platelets. We determined the NH2-terminal se- 
quence of  a prominent 110-kD  protein that becomes associated with 
cytoskeletons of  thrombin-activated platelets. With  the exception of 
two cysteine residues at amino acids 8 and 9 which could not be 
identified because the protein was not derivatized before sequenc- 
ing, the first fifteen amino acids of the 110-kD  protein are identical 
to the amino terminal sequence of 7-fibrinogen (7-Fbg). 
position and platelet aggregation were obtained for platelets 
activated in the presence of divalent cation chelators at 37°C 
(see Materials and Methods for details), a condition which 
has repeatedly been shown to completely prohibit platelet 
aggregation (Fitzgerald and  Phillips,  1985;  Shattil et al., 
1985a; Pidard et al., 1986). Platelet aggregation is therefore 
not required to yield the level of GPl/b-IIIa-cytoskeleton as- 
sociation that we observe by Western immunoblot analysis. 
The cytoskeletons of resting and thrombin-activated plate- 
lets were also analyzed by Western immunoblot for the pres- 
ence of talin, ot-actinin,  and vinculin, proteins postulated to 
be involved in membrane-cytoskeleton interactions. In con- 
trast to our findings for GPl/b-lna (Fig. 6 A), talin, ct-actinin, 
and vinculin are detected exclusively  in supernatants isolated 
from both resting and thrombin-activated platelets (Fig. 6, 
B-D).  It is possible that very small, undetectable amounts 
of talin,  vinculin, and/or c~-actinin are associated with the 
actin cytoskeleton; however, by characterizing the detection 
limits of our Western immunoblot assays,  we have deter- 
mined that no greater than 1% of the total platelet comple- 
ment of each of these proteins is associated with our isolated 
cytoskeletal pellets. 
In previous studies designed to examine the incorporation 
of GPIlb-IIIa into the actin cytoskeleton, researchers ob- 
served GPIIb-IIIa associated with cytoskeletons only after 
platelet aggregation (see for example Phillips et al.,  1980; 
Jennlngs et al.,  1981; Painter and Ginsberg, 1982; Wheeler 
et al.,  1984).  However, in these studies,  lactoperoxidase- 
catalyzed radioiodination of surface glycoproteins was used 
to monitor the cytoskeletal association of GPIIb-IIIa.  In- 
terestingly,  in  addition  to  plasma  membrane-associated 
GPIIb-l/Ia, resting platelets also contain an internal pool of 
GPIIb-I/Ia associated with the membranes of a-granules and 
the deeper regions of the surface-connected canalicular sys- 
tem (SCCS) that is not available for surface labeling (Gog- 
stadet al., 1981; Stenberg et al., 1984; Wencel-Drake et al., 
1986; Woods et al.,  1986). Consequently, we hypothesized 
that the cytoskeleton-associated GPIIb-IIIa that we detect by 
Western immunoblot could be derived from the internal pool 
Table L Analysis of Cytoskeleton-Associated GPllb-llla 
Platelet samples  GPIlb-Illa 
(Cytoskeletal pellets)  (% of total)  (n)  (SEM) 
Resting  2.4  10  0.6 
Thrombin-activated  21.9  11  1.7 
Figure 6. GPI~-II'Ia can associate with the platelet cytoskeleton in 
a  talin-,  c~-actinin-, and  vinculin-independent manner. Resting 
platelet supernatants (Rs), resting platelet pellets (Rp), activated 
platelet supematants (As), and activated platelet pellets (.4/9) were 
examined by Western immunoblot analysis for the  presence  of 
GPllb-llIa (A; lib, Ilia), talin (B; T), ct-actinin (C; oA), and vincu- 
lin (D; V). As loaded on the gels, pellet samples are five times more 
concentrated than supernatant samples. In contrast to our finding 
that the amount of  GPIIb-IIIa associated with the actin cytoskeleton 
pellet increases upon thrombin-activation of  platelets (A), talin (B), 
ct-actinin (C),  and vinculin (D) are detected exclusively in the 
detergent-soluble  fractions  from  both  resting  and  thrombin- 
activated platelets suggesting  that these proteins are not required for 
the maintenance of  the association between GPIIb-IIIa and the actin 
cytoskeleton of thrombin-activated, nonaggregated platelets. In the 
experiment shown in this figure, platelets were activated in the pres- 
ence of EGTA/EDTA to ensure that no aggregation took place in 
the thrombin-activated samples; however, as noted in the text, the 
same results are obtained if platelets are activated in the presence 
of divalent cations, and chelators are added 1 rain before cell lysis. 
of GPIIb-IIIa, an interaction which would not be detected by 
examination  of surface-labeled GPIIb-l/Ia.  To  investigate 
this possibility more rigorously, we compared the two differ- 
ent approaches for monitoring GPIIb-IIIa in parallel experi- 
ments (Fig. 7). Consistent with the results described above 
(Fig. 4), we observed a significant increase in cytoskeleton- 
associated GPllb-lIIa in response to thrombin activation when 
we used an immunological method for detecting GPIIb-ma 
(Fig.  7 A);  in contrast, we observed only a  negligible in- 
crease in GPllb-IIIa associated with the actin cytoskeleton 
upon platelet activation when the protein was tagged by sur- 
face iodination (Fig.  7 B).  Specifically, we found that the 
amount of surface-iodinated GPllb-I/Ia  that  becomes as- 
sociated with the actin cytoskeleton increases by less than 
twofold upon thrombin activation in contrast to the ninefold 
increase in cytoskeleton-associated  GPIIb-UIa that we detect 
by Western immunoblot.  The experiment shown in Fig.  7 
was performed in the presence of EGTA/EDTA to ensure 
that  no  aggregation  took place  in  the  thrombin-activated 
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tin cytoskeleton of thrombin-activated  platelets.  Actin cytoskele- 
tons were isolated from unlabeled platelets and platelets whose sur- 
face proteins had been iodinated  using a lactoperoxidase-catalyzed 
radioiodination procedure. S, detergent-soluble  supernatant (lanes 
I and 3); P, detergent-insoluble  pellet (lanes 2 and 4). By Western 
immunoblot (A) we detect a significant  increase in the amount of 
GPIIb-IIIa  associated with actin cytoskeletons upon thrombin acti- 
vation (compare lane 2 to lane 4). However, the amount of surface- 
iodinated  GPIIb-IIIa associated with activated  cytoskeletons does 
not increase  significantly  from the resting  level (B, compare lane 
2 to lane 4).  In this  representative  experiment, the percentage of 
the total amount of radiolabeled GPIIb-ma present in cytoskeletal 
pellets (B) increased from 3% in the resting sample (lane 2) to 4% 
in the activated sample (lane 4). These results suggest that the ma- 
jority of cytoskeleton-associated GPIIb-ma detected  by Western 
immunoblot is derived from an intracellular  pool of GPIIb-IIIa  that 
is unavailable  for surface-labeling. 
samples. However, similar results were obtained when plate- 
lets were activated in the presence of divalent cations and the 
absence of stirring with the addition of chelators only 1 min 
before lysis (not shown). Based on these results,  we believe 
that the use of Western immunoblot analysis has enabled us 
to detect the cytoskeletal  incorporation of an intracellular 
GPIIb-IIIa pool  which  is  inaccessible  to  lactoperoxidase- 
catalyzed radioiodination and therefore was not detected in 
previous studies in which only the surface-iodinatable pool 
of GPIlb-IIIa was examined. 
Although we found an increase in GPIIb-IIIa-cytoskele- 
ton association upon thrombin activation of platelets,  it was 
surprising that GPIIb-IIIa appears to be associated with the 
platelet cytoskeleton in the absence of  a number of other pro- 
teins  postulated  to  be  essential  for integrin-actin  interac- 
tions.  It was therefore critical to ascertain whether GPIIb- 
IIIa is  specifically  associated  with  the  actin  cytoskeleton 
or if it is merely cosedimenting with actin. Zucker and Ma- 
siello's observation (1983) that significant amounts of phos- 
pholipids  are  present  in  detergent-insoluble  cytoskeletons 
Figure 8.  Inhibition  of actin polymerization by cytochalasin D 
blocks the incorporation of  GPl/b-ma into the activated platelet cy- 
toskeleton. Platelets  were incubated in buffer plus or minus cyto- 
chalasin D  for one hour before platelet  activation.  15 min after 
thrombin addition,  detergent-soluble  and insoluble  fractions were 
isolated from resting and activated samples.  (A) A Coomassie blue- 
stained gel of molecular mass standards (M; lane 1 ); total human 
platelet  protein  (TP;  lane 2);  resting  platelet  supernatants  (Rs; 
lanes 3 and 7); resting platelet pellets (Rp; lanes 4 and 8); activated 
platelet  supernatants  (As; lanes 5 and 9); and activated platelet pep 
lets (Ap; lanes  6 and 10).  (B) A corresponding Western immuno- 
blot probed with antibody directed against GPllb-IIIa reveals that 
cytochalasin D blocks the activation-dependent  increase in GPIIb- 
IIIa associated  with the actin cytoskeleton (compare lane 6' with 
lane 10'). In this example, pellets are five times more concentrated 
than supernatants  in order to detect changes in the amount of  GPIIb- 
ma associated  with the actin cytoskeleton. Densitometric analysis 
of gels in which smaller amounts of sample were loaded revealed 
that cytochalasin D-treated activated  platelets  contain 20%  less 
sedimentable actin than control samples.  The cytochalasin D car- 
rier, ethanol, had no detectable effect on either actin content or the 
cytoskeletal incorporation of GPIIb-ma (not shown). 
isolated from aggregated platelets raised the possibility that 
nonspecific  trapping  of GPllb-ma-containing  membrane 
vesicles by actin filaments could occur during the cytoskele- 
ton isolation procedure and lead to the recovery of GPIlb- 
IIIa in the detergent-insoluble pellet.  We do not believe that 
this is the case in our experiments  for three reasons.  First, 
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of pelleted filamentous actin and the amount of GPIIb-IIIa 
recovered in the cytoskeletal pellet. For example, as can be 
seen in Fig. 4 A, there is a significant amount of filamentous 
actin present in cytoskeletons isolated from resting platelets 
but relatively little GPIIb-llla present in these samples (Ta- 
ble I). Moreover, quantitative analysis of  the amounts of  both 
actin and GPRb-IIIa in the isolated cytoskeletons revealed 
no direct correlation between the amount of sedimented actin 
and integrin (data not shown). Second, the fact that the in- 
corporation  of GPllb-IIIa  into  the actin  cytoskeleton is 
selective,  and  results  primarily  from an internal pool  of 
GPIIb-IIIa, argues against the general, nonspecific associa- 
tion of GPllb-l]Ia with the cytoskeleton. Third, although in- 
tracellular GPHb-lIIa is  detected in the activated platelet 
cytoskeleton, this GPIlb-llIa cannot result from trapping of 
or-granule membranes since another or-granule membrane- 
associated protein,  P-selectin (McEver,  1990),  is  not de- 
tected in our isolated actin cytoskeletons (data not shown). 
Collectively, these observations suggest that the incorpora- 
tion of GPIIb-IIIa into the actin cytoskeleton occurs via a 
selective, activation-dependent mechanism and is not the re- 
sult of nonspecific trapping of GPllb-IIIa-containing mem- 
brane vesicles during the isolation of the detergent-insoluble 
material. 
To test further whether GPIIb-llIa is sedimenting by virtue 
of a specific association with the actin cytoskeleton, we ex- 
amined the effect of cytochalasin D on the incorporation of 
GPIIb-RIa into the detergent-insoluble pellet. Incubation of 
platelets in cytochalasin D before thrombin addition blocks 
the activation-dependent increase in the amount of filamen- 
tous actin present in the actin cytoskeleton, but does not 
cause  appreciable  disassembly of actin  filaments already 
present in resting platelets (Fox and Phillips, 1981; Casella 
et  al.,  1981). Treatment of platelets with cytochalasin D 
blocks  the  incorporation of GPl/b-IIIa  into the  activated 
platelet cytoskeleton (Fig. 8 B, compare lanes 6' and 10'). 
This result suggests that the sedimentation of  GPIIb-IIIa with 
the actin cytoskeleton is dependent on the polymerization of 
filamentous actin and/or the assembly of these filaments into 
the actin cytoskeleton. 
We  also  addressed  the  possibility  that  GPIIb-IIIa  was 
sedimenting by virtue of an association with fibrin polymers 
and not with the actin cytoskeleton. Fibrinogen consists of 
et,/3, and ~/chains of •68  kD, 55 kD, and 50 kD, respec- 
tively (Fig. 9 A, lane 2). In a multi-step process thrombin- 
mediated cleavage of fibrinogen generates fibrin monomers 
which further associate into polymers (for review see Doo- 
little, 1984). The rate at which fibrin monomers polymerize 
is Ca2+-dependent (Boyer et al,,  1972;  Brass et al.,  1978). 
Because fibrin polymers are detergent-insoluble (Casella et 
al., 1983),  it is feasible that sedimentable fibrin could medi- 
ate the association of GPRb-IIIa with the detergent-insoluble 
pellet in the absence of any interaction between GPl/b-IIIa 
and the actin cytoskeleton. Using Western immunoblot anal- 
ysis, we compared the amount of GPIIb-IIIa with the amount 
of fibrin polymer in actin cytoskeletons isolated from resting 
and thrombin-activated platelets in the presence or absence 
of Ca  2+  and  Mg  2÷  (Fig.  9  B).  Anti-fibrinogen antibody 
recognizes fibrinogen subunits (Fig. 9 B, lane 2') as well as 
covalently associated high molecular weight fibrin species in 
activated platelets maintained in the presence of Ca  2+ and 
Figure 9. The association of GPllb-HIa with the cytoskeletal  pellet 
is independent of fibrin sedimentation. The relevant portion of a 
Coomassie blue-stained gel is shown in (A) lane 1, molecular mass 
standards (M); lane 2, human fibrinogen  (Fbg); lane 3, total human 
platelet protein (TP); lanes 4 and 6, resting platelet pellets (Rp); 
and lanes 5 and 7, activated platelet pellets (Ap). The detergent- 
insoluble  pellets shown  in lanes 4 and 5 were isolated from platelets 
incubated with Ca++/Mg  ++ during platelet activation with the addi- 
tion of EGTA/EDq'A 1 min before lysis; the samples in lanes 6 and 
7 were isolated from platelets activated in the presence of EGTA/ 
EDTA. (B) The corresponding Western immunoblot probed with 
anti-fibrinogen antibody which recognizes the ct, B, and "y chains 
of fibrinogen  (Fbg, arrows) as well as high molecular weight fibrin 
species. (C)  A parallel Western immtmoblot probed with anti- 
GPIIb-IIIa antibody.  High molecular weight fibrin species are prev- 
alent in cytoskeletons derived from platelets activated in the pres- 
ence of Ca++/Mg++ (lane 5'). Significantly  less fibrin polymer is 
detected in pellets isolated from samples containing EGTA/EITI'A 
(lane 7'). However, comparable amounts of GPHb-IIIa are present 
in both samples (compare lane 5" to lane 7"). 
Mg  2+  (see  for  example  Fig.  9  B,  lane  5').  Detergent- 
insoluble pellets isolated from platelets activated in the pres- 
ence of EGTA/EDTA contain significantly fewer high mo- 
lecular weight fibrin species (Fig. 9 B, lane 7'). We observed 
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of P-selectin  in  resting  and 
thrombin-activated  platelets. 
(a, c, and e) Differential inter- 
ference contrast micrographs; 
(b,  d,  and  f)  indirect  im- 
munofluorescence.  Rhodamine- 
labeled S12 monoclonal anti- 
body against P-selectin reveals 
the  distribution  of P-selectin 
on the surfaces of nonpermea- 
bilized platelets. Resting  plate- 
lets (a) have very  little P-selec- 
tin on their surfaces (b). Upon 
thrombin  activation (c),  sig- 
nificantly  more  cells  have 
surface membrane-associated 
P-selectin, as seen in d. Throm- 
bin-activated cells (e) labeled 
with secondary antibody alone 
are shown in f.  Bar,  5  #m. 
comparable amounts of GPl/b-llIa in cytoskeletons isolated 
from platelets activated in the presence (Fig.  9  C, lane 5") 
or absence (Fig. 9  C, lane 7') of divalent cations. The lack 
of correlation between the amount of fibrin and the amount 
of GPIIb-IIIa present in  the activated actin cytoskeletons 
suggests that the incorporation of GPl/b-IIIa into the deter- 
gent-insoluble pellets cannot be explained by an association 
of GPllb-l/Ia with pelletable fibrin polymers. The isolated 
integrin-cytoskeleton complexes do  exhibit an  activation- 
dependent  increase  in  the  level  of associated  fibrinogen 
which is presumably bound to GPl/b-IIIa. 
Our results suggest that intracellular GPllb-IIIa becomes 
selectively  incorporated  into  the  actin  cytoskeletons  of 
thrombin-activated platelets.  Intracellular stores of GPIIb- 
IIIa are associated with the membranes of the SCCS and 
a-granules of resting platelets (Wencel-Drake et al.,  1986). 
Upon thrombin activation and subsequent a-granule secre- 
tion, intracellular GPIIb-IZIa is translocated to the plasma 
membrane where it can participate in the adhesive response 
of platelets to stimuli (Stenberg et al.,  1984; Wencel-Drake 
et al., 1986). It is therefore feasible that the linkage between 
intracellular GPIlb-IIIa and the reorganizing actin cytoskele- 
ton is dependent on the secretory process. To investigate the 
possible role of a-granule  secretion in  the  association of 
intracellular GPITo-IIIa with the actin cytoskeleton, we ex- 
amined whether there is a  relationship between thrombin- 
induced  a-granule  secretion  and  the  incorporation  of 
GPI/b-l/Ia into the actin cytoskeleton. We first determined 
whether  a-granule  secretion occurs under the  conditions 
used in our studies by monitoring the exposure of  the a-gran- 
ule marker, P-selectin, on the platelet surface upon activation 
(Hsu-Lin et ai.,  1984; Stenberg et al., 1985; Berman et al., 
1986).  As  can be  seen in  Fig.  10,  surface expression of 
P-selectin is low in resting platelets and increases dramati- 
cally in thrombin-activated platelets.  These results are ex- 
pressed quantitatively in Table II. The activation-dependent 
increase  in  S12  staining  of  platelets  demonstrates  that 
a-granule  secretion  does  occur during  thrombin-induced 
platelet activation under our buffer conditions. 
To  address  more  directly the  relationship  between  the 
cytoskeletal association of GPllb-Ifla and a-granule secre- 
tion, we monitored the incorporation of GPIIb-IIIa into the 
cytoskeletons of platelets activated with ADP, a weak plate- 
let agonist. Platelet activation was confirmed by examining 
fixed samples of ADP-activated platelets for shape change 
and granule centralization by phase contrast and differential 
interference contrast microscopy. By following the surface 
expression of P-selectin, we identified activation conditions 
under which a-granule secretion is greatly diminished. For 
Table II. Analysis of Cell-Surface  Expression of P-Selectin 
Experimental  condition  % of S12-1abeled cells* 
Resting  +  buffer 
+  Metabolic  inhibitors 
Activated  +  thrombin 
+  ADP 
+  ADP  +  thrombin 
+  Metabolic  inhibitors 
+  thrombin 
10.8  +  3.0  (n  =  6) 
4.7  +  1.0 (n =  2) 
90.4 + 2.5 (n  = 4) 
21.1  + 7.6 (n  =  2) 
84.7 +  1.4 (n  =  2) 
5.6 +  1.2 (n  =  2) 
Greater  than 300 cells were counted per condition,  per experiment. 
* These  data represent  the average  of results  from independent experiments 
using different blood donors.  Each value represents  the mean  +  SEM. 
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GPllb-llla into the actin  cytoskeleton.  (A) A Coomassie  blue-stained 
gel of molecular mass standards (M, lane 1 ); total human platelet 
protein (T, lane  2); supernatants  from resting  platelets  (lane 3); ADP- 
activated  platelets  (lane  5), ADP + thrombin-activated  platelets  (lane 
7), and thrombin-activated  platelets (lane 9); pellets from resting 
platelets (lane  4), ADP-activated  platelets  (lane  6), ADP + thrombin- 
activated platelets (lane 8); and thrombin-activated  platelets (lane 
10). (B) A corresponding Western immunoblot probed with anti- 
body directed against  GPllb-IIIa. Actin cytoskeletons  isolated from 
ADP-activated  platelets (lane 63 (which exhibit minimal c~-granule 
secretion: Table  II) contain less GPllb-IIIa than those isolated from 
ceils activated with ADP followed  by thrombin (lane 8') or throm- 
bin alone (lane 10'), conditions that trigger extensive  alpha granule 
secretion. 
example, upon activation of washed platelets for 15 min with 
100  gM  ADP,  only 21%  of the  cells  exhibited  surface- 
exposed P-selectin compared with 90%  of cells activated 
with thrombin (Table II). We also detected less GPIIb-IIIa 
in cytoskeletal pellets isolated from ADP-activated platelets 
(Fig.  11  B, lane 6') than from thrombin-activated platelets 
(Fig.  11  B,  lane 10').  The addition of thrombin to plate- 
lets that were initially activated with ADP resulted in an 
increase  in  the  percentage  of cells  displaying peripheral 
P-selectin labeling (Table II) and a corresponding increase 
in  the  amount of GPIIb-ma  incorporated  into  the  actin 
cytoskeleton (Fig.  11  B, lane 8').  Our results demonstrate 
that there is a positive correlation between a-granule secre- 
tion  and  the  incorporation  of GPIIb-ma  into  the  actin 
cytoskeleton of activated platelets. 
Further  evidence  that  there  is  a  relationship  between 
a-granule secretion and the incorporation of GPIIb-IIIa into 
the actin cytoskeleton was obtained by examining the effect 
of inhibitors of a-granule release on the activation-depen- 
dent incorporation of GPHb-IIIa into the detergent-insoluble 
material. Incubation of resting platelet samples in 15 mM 
2-deoxyglucose and 20 mM gluconolactone (Holmsen et al., 
1974; Tuszynski et al., 1982) for 5 min before thrombin ad- 
dition resulted in nearly complete inhibition of a-granule 
secretion as evidenced by a lack of  $12 binding on the platelet 
surface (Table II). Under these conditions, we detected only 
a small activation-dependent increase in the amount of actin 
cytoskeleton-associated GPIIb-IIIa  (data  not  shown)  that 
was comparable to the increase in the amount of surface- 
iodinated GPl/b-ma detected in the actin cytoskeletons from 
thrombin-activated platelets (Fig. 7 B). 
Discussion 
When platelets become activated and adhesive, they estab- 
lish a transmembrane connection between their actin cyto- 
skeletons and the extracellular matrix. The molecular mech- 
anism  by  which  platelets  generate  this  linkage  is  not 
thoroughly understood. Using a biochemical approach we 
have examined the establishment of integrin-cytoskeleton 
linkages in thrombin-activated platelets. Here we report that 
a  significant portion  (22%)  of the  total  platelet pool  of 
GPlIb-HIa,  the most abundant platelet integrin, becomes 
selectively and stably associated with the actin cytoskeleton 
upon platelet activation and a-granule secretion. This as- 
sociation is independent of the platelet aggregation response. 
The incorporation of GPl/b-IIIa into the detergent-insoluble 
actin cytoskeleton of thrombin-activated platelets appears to 
be specific based on the following criteria:  (a) It is not an 
artifact caused by trapping of GPHb-IIIa with the filamen- 
tous actin pellet since there is no direct correlation between 
the amount of peUetable  actin and the amount of GPllqa-IIIa 
associated with the cytoskeletons; (b) It is cytochalasin D 
sensitive which suggests that activation dependent actin po- 
lymerization and/or cytoskeleton reorganization is essential 
for the incorporation of GPllb-IIIa into the actin cytoskele- 
ton; (c) It is detected even in the absence of extensive fibrin 
polymerization and sedimentation; therefore, the GPIIb-IIIa 
is not sedimenting by virtue of  an association with fibrin; and 
(d) It does not result from trapping of a-granule membranes 
since the a-granule membrane marker,  P-selectin,  is  not 
cytoskeleton-associated.  Collectively,  these  observations 
suggest that GPHb-IIIa sediments by virtue of a specific as- 
sociation with the actin cytoskeleton. The interaction be- 
tween GPIIb-IIIa and the actin cytoskeleton that we observe 
could mediate a  transmembrane link between the platelet 
contractile machinery and the substratum. 
Our ability to detect an aggregation independent interac- 
tion between intracellular GPl/b-lIIa and the actin cytoskele- 
ton contrasts with previous findings reported by other groups 
(Phillips et al., 1980; Painter and Ginsberg, 1982; Wheeler 
et al.,  1984) and absolutely depends on (a) the addition of 
divalent cation chelators at least 1 min before detergent lysis 
of the platelets, and (b) the use of Western immunoblot anal- 
ysis to detect cytoskeleton-associated GPIIb-ma.  We be- 
lieve that chelation of divalent cations contributes to the sta- 
bility of the cytoskeletal complexes by reducing the activity 
of  calcium-dependent  proteases  (Phillips  and  Jakabova, 
1977; Fox et al.,  1985) and actin severing proteins such as 
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tors,  our cytoskeletal pellets are smaller and contain sig- 
nificantly less actin, myosin, and GPIIb-IHa. Moreover, the 
use of Western immunoblot analysis in our studies allows us 
to detect all immunoreactive forms of GPIIb-IIIa. Of partic- 
ular interest, we have determined that a significant amount 
of the GPIIb-IIIa that we detect in the actin cytoskeletons 
isolated from activated platelets is derived from a pool of 
GPllb-llla that is not accessible to lactoperoxidase-catalyzed 
surface labeling. Lactoperoxidase-catalyzed  radiolabeling of 
surface  membrane-associated  glycoproteins,  the  labeling 
method most commonly used in previous studies to examine 
the distribution of GPIlb-IIIa in detergent-soluble and in- 
soluble platelet fractions (Phillips et al.,  1980;  Painter and 
Ginsberg, 1982; Wheeler et al., 1985), does not label intra- 
cellular GPIIb-IIIa pools that are associated with the mem- 
branes  of a-granules and the deep recesses of the SCCS 
(Gogstad et al.,  1981; Woods et al.,  1986).  Consequently, 
interactions between the cytoskeleton and GPIIb-IIIa de- 
rived from these intraceUular pools would not be detected in 
studies employing surface iodination to monitor GPllb-IIIa. 
Indeed, in agreement with previous workers (Phillips et al., 
1980),  we found that the amount of surface-labeled GPIIb- 
IIIa associated with the actin cytoskeletons increases by less 
than twofold upon thrombin activation. In contrast, by using 
Western immunoblots to detect GPIIb-IlIa,  we observe a 
much larger ninefold increase in the amount of total platelet 
GPIIb-IIIa present in actin cytoskeletons after thrombin acti- 
vation  (Table  I).  The majority of cytoskeleton-associated 
GPIIb-IIIa that  we  detect by  Western  immunoblot must 
therefore be derived from a-granule or SCCS-derived Cin- 
tracellular') pools that are not labeled by surface iodination. 
Our finding that a specific subpopulation of the platelet's 
complement of GPIIb-IIIa preferentially associates with the 
actin cytoskeleton in activated, nonaggregated platelets rep- 
resents a clear example of the subcellular heterogeneity of 
integrins and raises the question of  how the selective associa- 
tion of GPIIb-IIIa with the actin cytoskeleton is regulated. 
It is possible that functionally  distinct pools of  GPIlb-ffla are 
spatially segregated or are specified by ligand binding capac- 
ity,  posttranslational  modifications,  or  isoform diversity. 
Isenberg et al. (1987) have shown that ligand binding induces 
the clustering of GPIIb-I]Ia on the platelet surface and have 
suggested that receptor engagement triggers the formation of 
integrin-cytoskeleton linkages. In a washed platelet system 
such as the one we used in our experiments, or-granule and 
SCCS-derived GPIIb-IIIa would be the first pools of GPIIb- 
IIIa to be exposed to ligands released by a-granule exocyto- 
sis upon thrombin stimulation. Thus, if ligand binding were 
prerequisite to integrin-cytoskeleton attachment, these so- 
called intracellular pools of GPIIb-IIIa would be the first to 
associate with the cytoskeleton. This interpretation is con- 
sistent with our finding that fibrinogen is associated with the 
cytoskeletons from activated platelets as well as our observa- 
tion that secretion of a-granule contents precedes integrin- 
cytoskeleton linkage. Interestingly, it has been estimated that 
a-granules contain enough fibrinogen to engage •30%  of 
the platelet GPl/b-IIIa receptors (Plow et al., 1986), a value 
similar to the 22 % of the cellular GPllb-l]Ia that we detect 
associated with the actin cytoskeletons of  thrombin-activated 
platelets after a-granule secretion. The accessibility of gran- 
ule stores of fibrinogen to intracellular GPIIb-IIIa may there- 
fore lead to the immediate engagement of these receptors and 
the incorporation of the liganded population of GPIIb-IIIa 
into  the  actin  cytoskeleton upon  platelet  activation  and 
a-granule secretion. 
Intracellular and plasma membrane GPIIb-IIIa could also 
be distinguished based on differential posttranslational modi- 
fication. For example, it has been shown that limited phos- 
phorylation of GPIIIa occurs upon platelet activation (Parise 
et al., 1990; Hillery et al., 1991). The selective phosphory- 
lation of a subpopulation of GPIIIa could lead to differences 
in the receptor's ability to associate with the cytoskeleton. 
Likewise, the molecular heterogeneity of GPll'b-IIIa could 
provide a structural basis for functional diversity. Two forms 
of GPIIb resulting from alternative mRNA splicing have 
been identified in human platelets (Bray et al., 1990).  Such 
variation in GPIlb subunits could define the population of 
GPIIb-lIIa that becomes associated with the actin cytoskele- 
ton of activated, nonaggregated platelets. 
It is interesting that the association between intracellular 
GPl/b-IIIa and the platelet cytoskeleton that we observe is 
activation-dependent but not aggregation-dependent. Plate- 
let aggregation is coupled to post-receptor signaling path- 
ways  including the activation of cellular tyrosine kinases 
(FerreU and Martin, 1989; Golden and Brugge, 1989). Acti- 
vation-dependent responses  that  occur  in  the  absence  of 
platelet aggregation, such as the cytoskeletal association of 
intracellular GPllb-IIIa, must therefore precede and be inde- 
pendent of platelet aggregation and subsequent downstream 
events in the signal transduction pathway. Indeed, the inte- 
grin-cytoskeleton linkage we observe may even be prerequi- 
site to the transmission of transmembrane signals. 
Somewhat surprisingly, our isolated integrin-cytoskele- 
ton complexes exhibited no detectable talin, vinculin, or 
a-actinin. In terms of the molecular mechanisms underlying 
the integrin-cytoskeleton association, our results are most 
consistent with the idea that either GPHb-IIIa can associate 
directly with actin (Painter et al., 1985a,b) or that some yet 
unidentified protein(s)  mediates this interaction.  Because 
platelets are specialized for adhesion and contain relatively 
large amounts of talin (Collier and Wang,  1982; O'Halloran 
et al., 1985; Beckerle et al., 1986), a-actinin (Rosenberg et 
al., 1981; Langer et al., 1984), and vinculin (Koteliansky et 
al., 1984; Langer et al., 1984; Rosenfeld et al., 1985),  it is 
probable that these proteins, which are involved in adhesive 
interactions in other cells, are also essential at some stage 
of the platelet adhesive response.  Other investigators have 
proposed  that these proteins  are  involved in aggregation- 
dependent, cytoskeleton-membrane interactions that are es- 
sential for clot retraction (Phillips et al., 1980; Langer et al., 
1984; Asyee et al., 1987; Kouns et al., 1991). Although from 
our results, talin, a-actinin, and vinculin do not appear to 
be essential for the maintenance of the association between 
GPl/b-IIIa and the actin cytoskeleton of thrombin-activated, 
nonaggregated platelets, it is possible that these accessory 
proteins  are  involved in  the  initial  establishment of ac- 
tin-membrane  interactions  or  in  the  stabilization and/or 
regulation of these associations in vivo. Since differences in 
experimental conditions, such as extraction buffer' and tem- 
perature are known to affect the recovery of proteins with the 
actin cytoskeleton (Rosenberg et al., 1982; Fox et al., 1988), 
it is possible that talin, a-actinin, and/or vinculin are as- 
sociated with the actin cytoskeleton in vivo but are not re- 
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not exclude the possibility that very small (<1%) but biologi- 
cally significant amounts of talin, ot-actinin, or vinculin may 
be associated with the cytoskeleton but are not detectable in 
our assay.  However, our ability to recover relatively large 
amounts of GPIIb-Ma associated with the actin cytoskeleton 
in the absence of detectable amounts of talin, ot-actinin, and 
vinculin suggests that these three proteins are not absolutely 
required  to  maintain  all  GPIIb-IIIa-actin  interactions  in 
platelets. 
In conclusion, we have found that a significant amount of 
the total GPIIb-Ma pool becomes incorporated into the actin 
cytoskeleton of thrombin-activated,  nonaggregated  platelets. 
Additionally, we have shown that the majority of cytoskele- 
ton-associated GPllb-Ma is derived from intracellular pools 
of GPllb-IIIa  which  could  include  GPHb-Ma  associated 
with the membranes of a-granules and/or the SCCS. It is not 
possible to distinguish absolutely between GPIIb-Ma mole- 
cules derived from these two internal pools since there is no 
way  to  selectively  label  or-granule  membrane-associated 
GPIIb-Ma.  Moreover,  immediately upon platelet activation 
and o~-granule secretion, ~granule membranes fuse with the 
SCCS and the o~-granule and SCCS pools are mixed (Sten- 
berg et al., 1984; Wencel-Drake et al., 1986). Although we 
have clearly demonstrated the selective incorporation of in- 
tracellular  GPIlb-Ma  into  the  actin  cytoskeleton  before 
platelet aggregation,  the importance of plasma membrane 
GPIIb-Ma for hemostasis and thrombosis should not be un- 
derestimated. Plasma membrane-derived GPIlb-Ma is also 
involved in the adhesive response of platelets and has been 
shown to be associated with the actin cytoskeletons isolated 
from aggregated  platelets (Phillips et al.,  1980).  The pref- 
erential association of the intracellular population of GPllb- 
Ma with the actin cytoskeleton before platelet aggregation 
may be important  in the establishment of adhesive interac- 
tions during the earliest phases of platelet activation. Future 
studies will be required to determine if the various pools of 
GPIIb-Ma in resting platelets differ in structure,  conforma- 
tion,  or  ligand-binding  ability  and  how  these  differences 
influence the function of GPIIb-IIIa in the platelet activation 
response. 
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